a public good project by the
Synthesis
Company
of California

© 2026

Frank Seibold | doi.page

0 works0 citations0 h-index

Frank Seibold

Allen Institute for Brain Science(US)City of Hope(US)Lindenhofspital(CH)Crohn's and Colitis UK(GB)Institute of Nutrition, Metabolism and Diabetes(CA)Icahn School of Medicine at Mount Sinai(US)

Publications by Year

Research Areas

Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Immunodeficiency and Autoimmune Disorders, Celiac Disease Research and Management

Most-Cited Works

→ Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci(2010)2,560 cited
→ Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47(2011)1,348 cited
→ Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI(2009)565 cited
→ Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial(2021)421 cited
→ TREM-1–expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases(2007)370 cited
→ Ulcerative colitis(2009)328 cited

→ Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies(2007)

284 cited

→ Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort(2015)269 cited

→ Crohn's Disease–Associated Adherent Invasive Escherichia coli Modulate Levels of microRNAs in Intestinal Epithelial Cells to Reduce Autophagy(2013)238 cited

→ Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.(1992)186 cited